• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDEAVOR SPRINT RX; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDEAVOR SPRINT RX; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Myocardial Infarction (1969); Reocclusion (1985); Thrombus (2101); Blood Loss (2597)
Event Date 09/28/2018
Event Type  Injury  
Manufacturer Narrative
Title: impact of angiographic coronary artery disease complexity on ischemic and bleeding risks and on the comparative effectiveness of zotarolimus-eluting vs.Bare-metal stents in uncertain drug-eluting stent candidates authors: giuseppe gargiulo, athanasios patialiakas, raffaele piccolo, attila thury, salvatore colangelo, gianluca campo, matteo tebaldi, imre ungi, stefano tondi , marco roffi , alberto menozzi, nicoletta de cesare , roberto garbo, emanuele meliga, luca testa, henrique mesquita gabriel, marco ferlini, francesco liistro, antonio dellavalle, pascal vranckx, carlo briguori, stephan windecker, marco valgimigli journal: international journal of cardiology year 2018 issue #:9.120 literature reference: doi.Org/10.1016/j.Ijcard.2018.09.120.If information is provided in the future, a supplemental report will be issued.
 
Event Description
A journal article was submitted which documents the post-hoc analysis of the zeus trial.The impact of coronary anatomic complexity measured by the syntax score on the differences in outcomes following zes and bms was assessed at 1 year.Patients were typicallyhigh risk patients with high risk of bleeding or thrombosis or at low restenosis risk.Medtronic endeavor sprint devices were used.Clinical event included cardiac and non cardiac death, stent thrombosis, restenosis, mi, stroke and bleeding incidences were reported in the population under review.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDEAVOR SPRINT RX
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key8173207
MDR Text Key130616706
Report Number9612164-2018-03677
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeSZ
PMA/PMN Number
P060033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 12/18/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/18/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/05/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age74 YR
-
-